Peringkat dalam Saham
#32145
Ainos, Inc. operates as a healthcare technology company, specializing in... Ainos, Inc. operates as a healthcare technology company, specializing in point-of-care diagnostics and the development of safe, novel treatments for various disease indications. Its current portfolio encompasses a COVID-19 antigen rapid test kit, which integrates with a cloud-based test management platform known as the Ainos App, offering both personal and enterprise applications. Other diagnostic developments include a COVID-19 nucleic acid test and point-of-care testing for volatile organic compounds. Furthermore, the company is progressing with Very Low-Dose Oral Interferon Alpha, an oral formulation engineered to leverage the wide therapeutic applications of IFN-a, and is actively developing a Synthetic RNA (sRNA) technology platform in Taiwan. Established in 1984, this San Diego, California-based firm was formerly known as Amarillo Biosciences, Inc. until its rebranding to Ainos, Inc. in May 2021.
Harga Saham
$1.49
Terakhir disinkronkan: 2026-08-17
Kapitalisasi Pasar
$10.94M
Perubahan (1 tahun)
-55.67%
Perdagangan Ainos, Inc. (AIMD)
Harga AIMD dengan kapitalisasi pasar B
Kapitalisasi pasar dari Ainos, Inc.(AIMD)
Kapitalisasi Pasar: $10.94M
Per August 2026, Ainos, Inc. memiliki kapitalisasi pasar sebesar $10.94M. Ini menjadikan Ainos, Inc. sebagai perusahaan 32145th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Ainos, Inc. dari 2021 hingga 2026
AIMD dibandingkan dengan 5 teratas stocks paling populer
| Harga AIMD |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.460T
|
+49,926,451.49%
|
|
|
|
|
$4.489T
|
+41,050,947.33%
|
|
|
|
|
$4.141T
|
+37,863,476.22%
|
|
|
|
|
$3.569T
|
+32,629,940.70%
|
|
|
|
|
$2.798T
|
+25,584,584.04%
|
